Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • Strategic win for Control Bionics as new HCPCS gets approved for NeuroNode
    Strategic win for Control Bionics as new HCPCS gets approved for NeuroNode
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • Great weather sets the stage for early harvest, Namoi Cotton anticipates blooming FY24 results
    • News

    Great weather sets the stage for early harvest, Namoi Cotton anticipates blooming FY24 results

    In anticipation of an early start to the 2023 harvest, cotton processing company Namoi Cotton (ASX: NAM) has undertaken a series of activities to ensure smooth operations and maximise yields. The favourable weather conditions experienced across its network of growers prompted the Company to commence preparations earlier than usual, setting the stage for a promising

    Read More
    Public
  • Spenda draws down another $2m from debt warehouse for bump in recurring revenue
    • News

    Spenda draws down another $2m from debt warehouse for bump in recurring revenue

    To thrive in today’s competitive business landscape, on-demand financing can create make-or-break opportunities for small businesses that need a quick capital injection to seize on opportunities. It’s a need being met by transaction service company Spenda (ASX: SPX) which is seeing an uplift in its B2B lending and financing products. Spenda initially secured a debt

    Read More
    Public
  • Jaxsta’s symphony struggles to find its rhythm, employs third CEO in two years
    • News

    Jaxsta’s symphony struggles to find its rhythm, employs third CEO in two years

    In what can be considered a rather intense game of musical chairs, music credits database company Jaxsta (ASX: JXT) has appointed its third CEO in less than two years—Josh Simons. Simons replaces Beth Appleton who was appointed to the role in April 2022. Now the former CEO, Appleton, commented, “I will relish my time at

    Read More
    Public
  • Invex struggles to recruit patients, witnesses test failures for its clinical trial for intracranial hypertension alleviating drug
    • News

    Invex struggles to recruit patients, witnesses test failures for its clinical trial for intracranial hypertension alleviating drug

    The pressure is on for biotech company Invex Therapeutics (ASX: IXC), which is not only struggling to recruit patients but is also dealing with underwhelming results for its flagship drug Presendin, tackling idiopathic intracranial hypertension (IIH). The Company has initiated a comprehensive assessment of its Phase IIH EVOLVE program, which explores the potential of Presendin

    Read More
    Public
  • Kip McGrath expects FY23 revenue to see 10% boost as education operators profit from increased subsidies
    • News

    Kip McGrath expects FY23 revenue to see 10% boost as education operators profit from increased subsidies

    Despite all the corporate cash grabs to profit from the Government’s Child Care Subsidy boost, there’s plenty of profit opportunity in the next age bracket up too with tutoring provider Kip McGrath (ASX: KME) issuing an earnings upgrade, primarily from rising demand for tuition services. Government-affiliated tutoring provider Kip McGrath forecasts a revenue boost, citing

    Read More
    Public
  • XRF Scientific launches xrTGA, a weight-temperature measuring device
    • News

    XRF Scientific launches xrTGA, a weight-temperature measuring device

    After an extensive product development process, lab instrument manufacturing company XRF Scientific (ASX: XRF) has launched a new product—xrTGA. xrTGA is a thermogravimetric analyser (TGA), an instrument which measures the weight of an object over time while heating it to different temperature points. The instrument comprises a sample-heating furnace and a precise weighing scale for

    Read More
    Public
  • INOVIQ’s breast cancer test outperforms leading approved test, plans for further validation
    • News

    INOVIQ’s breast cancer test outperforms leading approved test, plans for further validation

    Precision diagnostics company INOVIQ (ASX: IIQ) has achieved noteworthy results from an independent clinical validation study of its SubB2M/CA15-3 test for breast cancer detection. The study has reported high accuracy (87%), sensitivity (81%), and specificity (93%) for the test, outperforming a leading approved CA15-3 test. INOVIQ CEO, Dr Leearne Hinch, said, “The outstanding results from

    Read More
    Public
  • Can’t handle the heat: Tasfoods sells Shima Wasabi business to clear debt
    • News

    Can’t handle the heat: Tasfoods sells Shima Wasabi business to clear debt

    For wasabi lovers, the intense and pungent flavour is what draws them into taking a bite, and perhaps the burst of excitement and complexity to dishes are what keep them coming back. However, not everyone can handle the heat, and what if you can’t handle them from burning your nose? Same goes for TasFoods (ASX:

    Read More
    Public
  • Elsight receives $180k repeat order from Censys for its drone connectivity tech Halo
    • News

    Elsight receives $180k repeat order from Censys for its drone connectivity tech Halo

    If you are tired of hearing people drone on about the growth of drones over the past few years, prepare for it to not end anytime soon, seeing as drone tech is only advancing. Drone connectivity solutions company Elsight Limited (ASX: ELS) has received a repeat order from Censys Technologies Corporation, a leading US-based complete

    Read More
    Public
  • In low spirits: Lark Distilling forecasts $2 million sales decline citing inflationary pressure on booze
    • News

    In low spirits: Lark Distilling forecasts $2 million sales decline citing inflationary pressure on booze

    Aussie whisky and liquor company Lark Distilling Co (ASX: LRK) is not raising its glasses just yet, for growing inflationary pressures on households has left fewer people reaching out for a cold one. Lark reported a decline in its net sales for H2 FY23, forecast to be $7.4 million, down from $9.6 million in H1

    Read More
    Public
  • «
  • ‹
  • 101
  • 102
  • 103
  • 104
  • 105
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.